trial · primary record
Etripamil NS 70 mg
Tachycardia, Supraventricular
| Phase | Phase 3 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 500 |
| Primary completion | 2024-12-10 |
| Primary endpoint | Time to an adjudicated termination of a positively adjudicated episode of PSVT and conversion to sinus rhythm (SR) for at least 30 seconds within 30 minutes of start of study drug dosing |
| Registry ID | NCT05410860 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:47:05.947Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05410860
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.